Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.medcli.2021.04.010 http://scihub22266oqcxt.onion/10.1016/j.medcli.2021.04.010 34103164!8112281!34103164     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Clin+(Barc) 2022 ; 158 (8): 356-360 Nephropedia Template TP {{tp|p=34103164|t=2022. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia |pdf=|usr=}}{{34103164}} gab.com Text Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia JO: Med Clin (Barc) http://www.kidney.de/pget.php?&tw=1&pmid=34103164 #FOAvip BACKGROUND: Until now, the coronavirus disease 2019 (COVID-19) pandemic has affected more than 2.5 million individuals worldwide, with approximately 170,000 deaths. Currently, no treatments with robust evidence of clinical benefit exist, and utilization of experimental agents have been recommended by national and international guidelines as a part of clinical studies. METHOD: In this retrospective study, a total of 323 patients severe acute respiratory syndrome due to PCR-documented COVID-19 infection admitted in our unit were included. Patients were categorized into two groups as those who did or did not receive high dose intravenous vitamin C. we examined the effect of high dose intravenous vitamin C administered in addition to other commonly used agents on prognosis in patients with COVID-19 pneumonia. RESULTS: As compared to patients who did not receive vitamin C, those in the VC group were not significantly different in terms of the length of hospital stay (p=0.05), re-admission rate (p=0.943), admission to intensive care, need for advanced oxygen support (p=0.488), need for advanced medical treatment (p<0.001), and mortality (p=0.52). CONCLUSION: The limited evidence based on small samples precludes definitive conclusions regarding the potential efficacy of high dose vitamin C in these patients, indicating the need for further assessment within the context of clinical research. Twit Text FOAVip Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia ????Med Clin (Barc) http://www.kidney.de/pget.php?&tw=1&pmid=34103164 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34103164 #FOAvip English Wikipedia <ref>{{Cite pmid|34103164}}</ref> Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia #MMPMID34103164 Suna K; Melahat US; Murat Y; Figen OE; Ayperi O Med Clin (Barc) 2022[Apr]; 158 (8): 356-360 PMID34103164show ga BACKGROUND: Until now, the coronavirus disease 2019 (COVID-19) pandemic has affected more than 2.5 million individuals worldwide, with approximately 170,000 deaths. Currently, no treatments with robust evidence of clinical benefit exist, and utilization of experimental agents have been recommended by national and international guidelines as a part of clinical studies. METHOD: In this retrospective study, a total of 323 patients severe acute respiratory syndrome due to PCR-documented COVID-19 infection admitted in our unit were included. Patients were categorized into two groups as those who did or did not receive high dose intravenous vitamin C. we examined the effect of high dose intravenous vitamin C administered in addition to other commonly used agents on prognosis in patients with COVID-19 pneumonia. RESULTS: As compared to patients who did not receive vitamin C, those in the VC group were not significantly different in terms of the length of hospital stay (p=0.05), re-admission rate (p=0.943), admission to intensive care, need for advanced oxygen support (p=0.488), need for advanced medical treatment (p<0.001), and mortality (p=0.52). CONCLUSION: The limited evidence based on small samples precludes definitive conclusions regarding the potential efficacy of high dose vitamin C in these patients, indicating the need for further assessment within the context of clinical research. |*COVID-19[MESH] |*SARS-CoV-2[MESH] |Ascorbic Acid/therapeutic use[MESH] |Humans[MESH] |Prognosis[MESH]Effect of high-dose intravenous vitamin C on prognosis in patients wit(epmc).pdf DeepDyve Pubget Overpricing